Monitoring the effectiveness of anticoagulation control

International Journal of Health Care Quality Assurance

Volumn 18, Issue 1, 2005, Pages 7-14

  Utley, Martin ^a   Patterson, David ^b   Gallivan, Steve ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Auditing; Blood; Drugs; Outpatients; Quality control

Indexed keywords

ANTICOAGULANT AGENT;

AMBULATORY CARE; ARTICLE; DRUG MONITORING; HEALTH CARE QUALITY; HUMAN; INTERNATIONAL NORMALIZED RATIO; STANDARD; TREATMENT OUTCOME; UNITED KINGDOM; ANTICOAGULATION; DISEASE CLASSIFICATION; FOLLOW UP; MATHEMATICAL COMPUTING; MEDICAL RECORD; PROTHROMBIN TIME; QUALITY CONTROL;

AMBULATORY CARE; ANTICOAGULANTS; DRUG MONITORING; GREAT BRITAIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; QUALITY ASSURANCE, HEALTH CARE; TREATMENT OUTCOME;

EID: 18244381292     PISSN: 09526862     EISSN: None     Source Type: Journal    
DOI: 10.1108/09526860510576929     Document Type: Article

References (13)

1. British Committee for Standards in Haematology (1990), “Guidelines on oral anticoagulation: 2nd edition”, J. Clin. Pathol., Vol. 43, pp. 177-83.
2. Burghes, D. and Graham, A. (1980), Introduction to Control Theory Including Optimal Control, Ellis Horwood, Chichester.
3. Doble, N. and Baron, J.H. (1987), “Anticoagulation control with warfarin by junior doctors”, J. R. Soc. Med., Vol. 80, p. 627.
4. Haemostasis and Thrombosis Task Force – British Committee for Standards in Haematology (1998), “Guidelines on oral anticoagulation: 3rd edition”, Br. J. Haematol., Vol. 101, pp. 374-87.
5. Hirsch, J. et al. (1992), “Oral anticoagulation: mechanism of action, clinical effectiveness and optimal therapeutic ranges”, Chest, Vol. 102, pp. 312S-26S.
6. Holford, N.H.G. (1986), “Clinical pharmacokinetics and pharmacodynamics of warfarin – understanding the dose-effect relationship”, Clin. Pharmacokinet., Vol. 11, pp. 483-504.
7. Landefeld, C.S. and Beyth, R.J. (1993), “Anti-coagulant-related bleeding: clinical epidemiology, prediction, and prevention”, Am. J. Med., Vol. 95, pp. 315-28.
8. Lewis, S.M. (1998), “External quality assessment”, in Lewis, S.M. and Verwilghen, R.L. (Eds), Quality Assurance in Haematology, Balliere Tindall, London, pp. 151-75.
9. Poller, L. and Taberner, D.A. (1982), “Dosage and control of oral anticoagulants: an international collaborative survey”, Br. J. Haematol., Vol. 51, pp. 479-85.
10. Rose, P. (1996), “Audit of anticoagulant therapy”, J. Clin. Pathol., Vol. 48, pp. 5-9.
11. Vadher, B.D., Patterson, D.L. and Leaning, M.S. (1995), “Validation of an algorithm for oral anticoagulant dosing and appointment scheduling”, Clin. Lab. Haematol., Vol. 17, pp. 339-45.
12. Vadher, B.D., Patterson, D.L. and Leaning, M. (1997), “Comparison of oral anticoagulant control by a nurse-practitioner using a computer decision-support system with that by clinicians”, Clin. Lab. Haematol., Vol. 19, pp. 203-7.
13. Wells, P.S. et al. (1994), “Interactions of warfarin with drugs and food”, Ann. Intern. Med., Vol. 121, pp. 676-83.